Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. It possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided with diverse DMFs over the world, including Alfacalcidol, Calcipotriol, Paricalcitol, Tacalcitol etc.